Efficacy of interferon-α treatment in Japanese children with chronic hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 4, 2003, Pages 411-414

  Nakashima, Eisuke ^a   Fujisawa, Takuji ^a   Kimura, Akihiko ^a   Kage, Masayoshi ^a   Yamato, Yasuhiko ^a   Maeda, Kohji ^a   Kumagai, Masami ^a   Ushijima, Kosuke ^a   Yamashita, Yasuhiro ^a   Matsuishi, Toyojiro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Children; Chronic hepatitis C; Interferon treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; VIRUS RNA;

ADOLESCENT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER HISTOLOGY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0038557129     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03010.x     Document Type: Article

References (17)

1. Yousuf M, Nakano Y, Tanaka E, Sodeyama T, Kiyosawa K. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand. J. Gastroenterol. 1992; 27: 812-16.
2. Fujisawa T, Komatsu H, Inui A et al. Spontaneous remission of chronic hepatitis C in children. Eur. J. Pediatr. 1997; 156: 773-6.
3. Schwimmer JB, Balistreri WF. Transmission, natural history, and treatment of hepatitis C virus infection in the pediatric population. Semin. Liver Dis. 2000; 20: 37-46.
4. Kage M, Fujisawa T, Shiraki K et al. Pathology of chronic hepatitis C in children. Hepatology 1997; 26: 771-5.
5. Hoshiyama A, Kimura A, Fujisawa T, Kage M, Kato H. Clinical and histological features of chronic hepatitis C virus infection after blood transfusion in Japanese children. Pediatrics 2000; 105: 62-5.
6. Okamoto H, Okada S, Sugiyama Y et al. Detection of hepatitis C virus RNA by two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn. J. Exp. Med. 1990; 60: 215-22.
7. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with two type-specific primers: application to clinical surveys and tracing infection sources. J. Gen. Virol. 1992; 73: 673-9.
8. Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-4.
9. Brunt EM. Grading and stage the histological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 2000; 31: 241-6.
10. Ruiz-Moreno M, Rue MJ, Castillo I et al. Treatment of children with chronic hepatitis C with recombinant interferon-α: a pilot study. Hepatology 1992; 16: 882-5.
11. Bortolotti F, Giacchino R, Vajro P et al. Recombinant interferon-alfa therapy in children with chronic hepatitis C. Hepatology 1995; 22: 1623-7.
12. Komatsu H, Fujisawa T, Inui A et al. Efficacy of interferon in treating chronic hepatitis C in children with a history of acute leukemia. Blood 1996; 87: 4072-5.
13. Sawada A, Tajiri H, Kozaiwa K et al. Favorable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C. J. Hepatol. 1998; 28: 184-8.
14. Hagiwara H, Hayashi N, Mita E et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α. Hepatology 1992; 15: 37-41.
15. Kakumu S, Aiyama T, Okumura A, Iwata K, Ishikawa T, Yoshioka K. Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C. J. Gastroenterol. Hepatol. 1997; 12: 468-72.
16. Kanai K, Kato M, Omata H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1991; 339: 1543.
17. Mita E, Hayashi N, Hagiwara H et al. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig. Dis. Sci. 1994; 39: 977-82.